Metabolic effects of nandrolone decanoate and resistance training in men with HIV. (Q44185404)

30 November 2017

Metabolic effects of nandrolone decanoate and resistance training in men with HIV. (English)

1 reference

30 November 2017

Fred R Sattler

1

1 reference

30 November 2017

E Todd Schroeder

2

1 reference

30 November 2017

Michael P Dube

3

1 reference

30 November 2017

S Victoria Jaque

4

1 reference

30 November 2017

Carmen Martinez

5

1 reference

30 November 2017

Patricia J Blanche

6

1 reference

30 November 2017

Stanley Azen

7

1 reference

30 November 2017

Ronald M Krauss

8

1 reference

30 November 2017

27 August 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

30 November 2017

1 reference

30 November 2017

283

1 reference

30 November 2017

6

1 reference

30 November 2017

E1214-22

1 reference

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Testosterone dose-response relationships in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

How good a marker is insulin level for insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Testosterone and regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00189.2002

10.1152/AJPENDO.00189.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference